Medipharm Labs Corp (LABS) — Capital Reinvestment Ratio
Medipharm Labs Corp (LABS) has a Capital Reinvestment Ratio of 0.23x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$435.00K) in capital expenditures (CA$100.00K). Check Medipharm Labs Corp tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medipharm Labs Corp Capital Reinvestment Ratio (2017–2017)
This chart tracks Medipharm Labs Corp's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Medipharm Labs Corp (LABS) cash flow conversion.
Annual Capital Reinvestment Ratio for Medipharm Labs Corp (2017–2017)
Year-by-year Capital Reinvestment Ratio for Medipharm Labs Corp from 2017 to 2017. See LABS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 12.92x | CA$166.00K | CA$2.14 Million | — |